Behind the headlines
Dr David Robert Grimes looks at the eye health issues that are making the news.
Dr David Robert Grimes looks at the eye health issues that are making the news.
A landmark ruling promises to substantially reduce the cost of treating wet age-related macular degeneration (AMD) – and has significant implications for future drug policy. Bayer and Novartis had attempted to stop clinical commissioning groups (CCGs) from prescribing Avastin – a widely used and cheaper treatment, but unlicensed for AMD.
In September, the High Court ruled against the drug giants.
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.